Table 3 from Low OLFM1 and BMP6 Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance

Kenichi Suda; Yukihiro Yoshida; Hidenori Sato; Shuta Ohara; Akira Hamada; Masaya Yotsukura; Kouya Shiraishi; Ryuji Hamamoto; Yasutaka Chiba; Takashi Kohno; Yasushi Yatabe; Shun‐ichi Watanabe; Yasuhiro Tsutani; Tetsuya Mitsudomi

doi:10.1158/2767-9764.30908555

December 18, 2025

Table 3 from Low OLFM1 and BMP6 Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance

View at Publisher

Ask AI

Bookmark

Share

Key Points

To assess the predictive value of egfr expression for recurrence in early-stage nonsquamous NSCLC.
Conducted multivariable analysis
Analyzed recurrence-free survival and overall survival
Focus on patients with egfr mutation, cohort E, size 108
Identified association between egfr expression and recurrence-free survival
Findings suggest a potential predictive role of egfr for early-stage nonsquamous nsclc

Implication

Multivariable analysis shows association of egfr mutation with recurrence-free survival in early-stage nonsquamous nsclc, implying its potential as a predictive biomarker.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Suda et al. (2025) studied this question.

synapsesocial.com/papers/69449a922f0218eca9508784 https://doi.org/10.1158/2767-9764.30908555

View at Publisher

Ask AI

Bookmark

Share

Table 3 from Low OLFM1 and BMP6 Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance

Key Points

Implication

Abstract

Discussion

Cite This Study

Table 3 from Low OLFM1 and BMP6 Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading